By Sarah Owermohle, May 8, 2025
Universities across the country are scrambling to comply with President Donald Trump’s anti-diversity push in an effort to hold on to hundreds of millions of dollars in federal grants that fund critical medical research in areas such as cancer and maternal health.
Last month, the Trump administration threatened to cancel medical research funds and to pull the accreditation for universities that have diversity and inclusion programs and that boycott Israeli companies.
The latest moves broaden the anti-DEI mandate that Trump signed just hours into his second term, declaring diversity, equity and inclusion efforts discriminatory.
The administration is locked in a legal battle with Harvard University that on Monday saw officials cut off future funding, escalating a total freeze on $2.2 billion in federal grants directed to Harvard. The university has sued to unlock those funds, a fight that will likely be expensive, and take months to resolve.
Most universities, particularly public and smaller institutions, lack the resources to take up the fight the way Harvard has. Dozens of schools across the country have publicly ended DEI programs and quietly taken down or rerouted websites referencing diversity and equity. Some have more openly acquiesced to the administration’s demands, banning the use of certain words and phrases such as “equality,” “gender” and “White supremacy,” and laying off dozens of university staff.
But those efforts haven’t spared them from mass funding cuts.
At Columbia University, some $250 million in health research grants remain in limbo even after the university made significant policy changes in late March to placate the administration. Leaders at Ohio State University, Vice President JD Vance’s alma mater, acted early to end DEI programs and eliminate 16 staff positions in February, citing Trump’s mandate and a state bill.
But in March, the administration still canceled 10 grants to Ohio State, clawing back $2.4 million in planned spending on HPV and Covid-19 vaccine uptake and separate studies on substance use, suicide risk and PrEP access among different LGBTQ populations.
Starting in February, the US National Institutes of Health terminated roughly 780 research grants that referenced equity, racial disparities, minority health, LGBTQ populations and Covid-19. The canceled grants spanned the country: Roughly 40% were to organizations in states Trump won in November, according to a KFF analysis.
Those have included cuts to research seemingly squarely in line with the stated goals of the Trump administration and US Health and Human Services Secretary Robert F. Kennedy Jr., such as studies on autism diagnoses, chronic disease improvements and environmental exposures’ intersection with health.
Besides the immediate impact of frozen research and staff layoffs, scientists and public health experts worry about a chilling effect for health care studies overall. The NIH is the world’s largest public funder of biomedical research, issuing roughly 60,000 grants a year to nearly 3,000 universities and hospitals. That accounts for more than 80% of the agency’s current $48 billion annual budget, although the administration aims to slash that spending by a third next year.
“People are frightened,” said Diana Zuckerman, president of the National Center for Health Research, a nonprofit group aimed at improving health care research. “One of the things that I’ve said to people is, you know, ‘how much can you do what you’ve been doing but just call it something else?’”
That can be a tricky prospect for research on health care issues that disproportionately affect certain populations.
Medical researcher: We should be sharing vaccines with developing world
For instance, the US reports persistently high rates of maternal and infant deaths compared with other high-income countries. There are stark disparities within those figures: Black women are three times more likely to die of pregnancy-related causes than White women.
Researchers and state medical boards attribute those statistics to a range of factors including racial bias, health care access, underlying health conditions and socioeconomic status.
That makes it extraordinary difficult to strip equity, race and risks for certain populations from questions about maternal health care and other research, experts say. Whether it’s new mothers’ postpartum survival, HIV prevention in LGBTQ populations or higher risk of aggressive breast cancer in Black women, many studies necessitate a focus on the people most affected, those experts say. The NIH cut research in all those areas.
“There’s real issues here that could be better understood and responded to, and lives could be saved, but only if you study them – and only if you understand what you’re studying,” Zuckerman said.
Beyond hundreds of grants citing words such as equity, disparities, gender, minority, LGBTQ populations or race, the NIH also canceled spending on Covid-19 outreach, vaccination and messaging.
“HHS grants will only go to the most qualified applicants and will not adhere to ideological requirements or discriminatory quotas,” an HHS spokesperson said in response to questions about the canceled grants.
The mass culling of NIH grants has even stoked concern among Republican leaders who argue that the US could slide in medical innovation and world leadership with the combined funding cuts, mass layoffs and agency shakeups.
“We must not lose sight at what is truly at stake here,” Sen. Susan Collins, a Maine Republican, said during a Senate Appropriations hearing last week. “If clinical trials are halted, research is stopped and laboratories are closed, effective treatments and cures for diseases like Alzheimer’s, type 1 diabetes, childhood cancers and Duchenne muscular dystrophy will be delayed or not discovered at all.”
Maternal health and the DEI battle
In 2023, the NIH launched a $168 million initiative across 10 universities to improve maternal health care.
In March, the agency canceled funding to two of them.
Columbia University, one of the 10 maternal health centers in the mass NIH project, was one of the first schools ensnared in grant freezes and a public battle with the Trump administration.
But the broad grant cancellations also caught the Morehouse School of Medicine, part of a historically Black university in Atlanta, Georgia, a state with some of the worst maternal mortality rates in the country.
Along with Georgia’s Emory University, Morehouse stood up a program focused on improving pregnancy and postpartum care for Black women. There was $1.6 million remaining in the $2.9 million grant when the NIH cut funding. Morehouse School of Medicine President Valerie Montgomery Rice stood fast against anti-DEI efforts in February, telling local radio station WABE that “diversity, equity and inclusion, as it relates to health, is not a political term.”
[….]
“The reason that we knew that we were having disparities in our maternal outcomes is because we started disaggregating the data. We started looking at the outcomes for Black women and White women and Hispanic women,” said one OB/GYN researcher focused on maternal mortality. “If we’re not measuring it, we won’t do anything to improve, because we won’t know. It’s almost like sticking our heads in the sand.”
The researcher asked that their name not be used because they are affiliated with one of the still-funded maternal health programs and are fearful that research could be cut next. Although many of the remaining universities in the program have publicly ended their DEI programs, none feel safe, the person said.
[….]
MAHA priorities amid NIH cuts
Dozens of the cancellations seemingly clash with Kennedy’s vision for a healthier America with fewer chronic illnesses, researchers said. Those include at least two research projects aimed at autism, two focused on diabetes and others on cancer research in rural and underserved areas, and disparities in long-term chronic disease outcomes. In most cases, the grants explicitly mentioned a minority population, equity or disparities in care.
Many of those researchers were years, and thousands to millions of dollars, into their projects: Some were ending soon anyway, and had just a fraction of their grants left to spend.
[….]
Ohio State’s 10 canceled grants include one focused on substance use and associated chronic illnesses across sexual minorities in urban and rural areas. Of the nearly $173,000 grant, just $538.11 was left to be disbursed, according to federal data. The grant was cancelled on March 21; it was scheduled to end 10 days later.
[….]
At the Tulane School of Medicine, the $16 million grant for the maternal health center was untouched in March funding cuts. However, the administration did axe the remaining funding, roughly $279,000, for a $4.2 million grant to study lupus progression in Black Americans. Tulane also lost funding for research on Covid-19 treatment in cancer patients.
The medical school has since quietly removed and rerouted diversity pages on its website. The psychiatry department’s page on equity, diversity and inclusion now says that the content is unavailable: “Some content is currently under review to ensure compliance with the latest federal guidelines and executive orders.”
The president of Tulane University announced in a message to students and faculty on March 13 that it would transition its DEI program into a new “Office of Academic Excellence and Opportunity” to comply with federal law. Diversity pages now reroute to that site.
[….]
Read original article here.